Clinical characteristics of the EIA—UQ patient subgroup indicated accentuated initial cardiovascular risk: besides high incidence of hypertension, dyslipidaemia and diabetes mellitus, baseline cardiac biomarker (hsTnT) and necroenzymes levels (CK, CKMB, ASAT, LDH) were also elevated. Here, ABCB7 is linked to inherited lipid metabolism disorder.